Adjusting for patient selection suggests the addition of docetaxel to 5-fluorouracil–cisplatin induction therapy may offer survival benefit in squamous cell cancer of the head and neck-Reference-Cited by-同舟云学术

Adjusting for patient selection suggests the addition of docetaxel to 5-fluorouracil–cisplatin induction therapy may offer survival benefit in squamous cell cancer of the head and neck

Published:2004-04 Issue:4 Volume:15 Page:331-340
ISSN:0959-4973
Container-title:Anti-Cancer Drugs
language:en
Short-container-title:Anti-Cancer Drugs

Author:

Pignon Jean-Pierre,Syz Nathalie,Posner Marshall,Olivares Robert,Le Lann Laurence,Yver Antoine,Dunant Ariane,Lewin Freddi,Dalley David N.,Paccagnella Adriano,Taylor Samuel G.,Domenge Christian,Bourhis Jean,Mazumdar Madhu

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cancer Research,Pharmacology (medical),Pharmacology,Oncology

Reference28 articles.

1. Head and Neck Cancer in 1994: a Change in the Standard of Care

2. Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data

3. Randomized trial of neoadjuvant chemotherapy in oropharyngeal carcinoma

4. Phase III Trial of Initial Chemotherapy in Stage III or IV Head and Neck Cancers: a Study by the Gruppo di Studio sui Tumori della Testa e del Collo

5. Docetaxel (Taxotere®): An active drug for the treatment of patients with advanced squamous cell carcinoma of the head and neck

Cited by 59 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Oral Cancer Management;Peterson’s Principles of Oral and Maxillofacial Surgery;2022

2. Prognostic factor analysis and long-term results of the TAX 323 (EORTC 24971) study in unresectable head and neck cancer patients;European Journal of Cancer;2021-10

3. GANT61 Reduces Hedgehog Molecule (GLI1) Expression and Promotes Apoptosis in Metastatic Oral Squamous Cell Carcinoma Cells;International Journal of Molecular Sciences;2020-08-24

4. Assessment of Concurrent Chemoradiotherapy plus Induction Chemotherapy in Advanced Nasopharyngeal Carcinoma: Cisplatin, Fluorouracil, and Docetaxel versus Gemcitabine and Cisplatin;Scientific Reports;2018-10-22

5. Value of two-cycle docetaxel, cisplatin, and 5-fluorouracil induction chemotherapy in hypopharyngeal carcinoma;Neoplasma;2018